Stevens-Johnson syndrome
FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
Stevens Johnson syndrome is a severe and sometimes fatal form of erythema multiforme
- there is more widespread skin and mucosal involvement than in erythema multiforme
(1)
- although erythema multiforme (EM), Stevens-Johnson syndrome (SJS) and toxic
epidermal necrolysis (TEN) were thought to belong to the same group of disorders
there is supporting evidence that EM differs from the other 2 diseases in:
- clinical features
- severity
- cause
- dermographic variables (2)
- SJS is a rare, life threatening mucocutaneous condition with epidermal
detachment, acute skin blisters and erosions in the mucous membranes (3)
- detachment is seen in less than 10% of the total body surface areas (3)
- the disease can be seen in all ages including children, infants and sometimes
in newborns as well (2)
- there is a higher incidence in children and young adults, and it is twice as common in males than females. There may be pulmonary, gastrointestinal, cardiac or renal involvement (4)
With respect to systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome (5):
- found when compared to corticosteroids, etanercept may result in mortality reduction
- certainty of evidence for disease-specific mortality is very low for corticosteroids versus no corticosteroids, IVIG (intravenous immunoglobulins) versus no IVIG and cyclosporin versus IVIG
Reference:
- 1. Hackle J.G et al. Photo quiz - Rash in an adolescent. AFP 2004;70(3)
- 2. Gupta S, Devkaran A. Toxic epidermal necrolysis. Student BMJ 2008;16:168-170
- 3. Levi N et al. Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis. Pediatrics 2009;123: e297-e304 7
- 4. Segal A.R et al. Cutaneous Reactions to Drugs in Children. Pediatrics 2007;120:e1082-e1096
- 5. Jacobsen A, Olabi B, Langley A, Beecker J, Mutter E, Shelley A, Worley B, Ramsay T, Saavedra A, Parker R, Stewart F, Pardo Pardo J. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD013130. DOI: 10.1002/14651858.CD013130.pub2
Last edited 04/2022 and last reviewed 05/2022
Links: